##gff-version 3
##sequence-region Q9HC29 1 1040
Q9HC29	UniProtKB	Chain	1	1040	.	.	.	ID=PRO_0000004418;Note=Nucleotide-binding oligomerization domain-containing protein 2	
Q9HC29	UniProtKB	Domain	26	122	.	.	.	Note=CARD 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00046	
Q9HC29	UniProtKB	Domain	126	218	.	.	.	Note=CARD 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00046	
Q9HC29	UniProtKB	Domain	293	618	.	.	.	Note=NACHT;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00136	
Q9HC29	UniProtKB	Repeat	791	812	.	.	.	Note=LRR 1	
Q9HC29	UniProtKB	Repeat	816	839	.	.	.	Note=LRR 2	
Q9HC29	UniProtKB	Repeat	844	865	.	.	.	Note=LRR 3	
Q9HC29	UniProtKB	Repeat	872	884	.	.	.	Note=LRR 4	
Q9HC29	UniProtKB	Repeat	900	920	.	.	.	Note=LRR 5	
Q9HC29	UniProtKB	Repeat	928	949	.	.	.	Note=LRR 6	
Q9HC29	UniProtKB	Repeat	956	976	.	.	.	Note=LRR 7	
Q9HC29	UniProtKB	Repeat	984	1005	.	.	.	Note=LRR 8	
Q9HC29	UniProtKB	Repeat	1012	1032	.	.	.	Note=LRR 9	
Q9HC29	UniProtKB	Nucleotide binding	299	306	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00136	
Q9HC29	UniProtKB	Region	241	274	.	.	.	Note=Required for CARD9 binding;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24960071;Dbxref=PMID:24960071	
Q9HC29	UniProtKB	Motif	63	77	.	.	.	Note=ATG16L1-binding motif	
Q9HC29	UniProtKB	Alternative sequence	1	27	.	.	.	ID=VSP_018689;Note=In isoform 2 and isoform 3. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11087742,ECO:0000303|PubMed:20698950;Dbxref=PMID:11087742,PMID:20698950	
Q9HC29	UniProtKB	Alternative sequence	216	224	.	.	.	ID=VSP_046567;Note=In isoform 3. AATCKKYMA->DERTEAQKG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:20698950;Dbxref=PMID:20698950	
Q9HC29	UniProtKB	Alternative sequence	225	1040	.	.	.	ID=VSP_046568;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:20698950;Dbxref=PMID:20698950	
Q9HC29	UniProtKB	Natural variant	81	81	.	.	.	ID=VAR_036871;Note=L->V;Dbxref=dbSNP:rs34936594	
Q9HC29	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_073228;Note=In IBD1%3B unknown pathological significance. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15024686;Dbxref=dbSNP:rs104895468,PMID:15024686	
Q9HC29	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_012665;Note=In IBD1%3B also found in patients with ulcerative colitis%3B unknown pathological significance. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs34684955,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_012666;Note=In IBD1%3B unknown pathological significance. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895420,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_012667;Note=T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs61755182,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_012668;Note=In IBD1%3B unknown pathological significance. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895422,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_012669;Note=In IBD1%3B unknown pathological significance%3B no disruption of NOD2-CARD9 interaction. L->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:24960071;Dbxref=dbSNP:rs104895423,PMID:11385576,PMID:24960071	
Q9HC29	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_012670;Note=P->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:16485124,ECO:0000269|PubMed:25724124;Dbxref=dbSNP:rs2066842,PMID:11385576,PMID:16485124,PMID:25724124	
Q9HC29	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_012671;Note=N->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs5743271,PMID:11385576,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_012672;Note=In IBD1%3B unknown pathological significance. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895424,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_012673;Note=In IBD1%3B unknown pathological significance. T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895425,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_012674;Note=In IBD1%3B unknown pathological significance. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895426,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_012675;Note=In IBD1%3B also found in patients with ulcerative colitis%3B unknown pathological significance. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs104895427,PMID:11385576,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_012676;Note=In BLAUS%3B somatic mosaicism in 4.9%25 to 11%25 of peripheral blood cells%3B hyperactive%3B abolishes interaction with LDOC1%2C ANKHD1%2C PPP2R3B%2C ENTR1 and TRIM41%3B decreases interaction with RIPK2 and PPP1R12C%3B no effect on interaction with CHMP5. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11528384,ECO:0000269|PubMed:19116920,ECO:0000269|PubMed:19479837,ECO:0000269|PubMed:25093298,ECO:0000269|PubMed:25724124,ECO:0000269|PubMed:27812135;Dbxref=dbSNP:rs104895461,PMID:11528384,PMID:19116920,PMID:19479837,PMID:25093298,PMID:25724124,PMID:27812135	
Q9HC29	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_012677;Note=In BLAUS%3B no disruption of NOD2-CARD9 interaction%3B hyperactive. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11528384,ECO:0000269|PubMed:15459013,ECO:0000269|PubMed:19116920,ECO:0000269|PubMed:19479837,ECO:0000269|PubMed:20199415,ECO:0000269|PubMed:24960071,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895462,PMID:11528384,PMID:15459013,PMID:19116920,PMID:19479837,PMID:20199415,PMID:24960071,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_012678;Note=In IBD1%3B unknown pathological significance. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895428,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_012679;Note=In IBD1%3B unknown pathological significance. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs5743272,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	357	357	.	.	.	ID=VAR_073229;Note=In IBD1%3B unknown pathological significance%3B no disruption of NOD2-CARD9 interaction. D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15024686,ECO:0000269|PubMed:24960071;Dbxref=dbSNP:rs104895469,PMID:15024686,PMID:24960071	
Q9HC29	UniProtKB	Natural variant	363	363	.	.	.	ID=VAR_073230;Note=In IBD1%3B unknown pathological significance%3B no disruption of NOD2-CARD9 interaction. I->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15024686,ECO:0000269|PubMed:24960071;Dbxref=dbSNP:rs104895470,PMID:15024686,PMID:24960071	
Q9HC29	UniProtKB	Natural variant	373	373	.	.	.	ID=VAR_012680;Note=In IBD1%3B unknown pathological significance. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs145293873,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	382	382	.	.	.	ID=VAR_023822;Note=In BLAUS%3B hyperactive. D->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15459013,ECO:0000269|PubMed:19116920;Dbxref=dbSNP:rs104895476,PMID:15459013,PMID:19116920	
Q9HC29	UniProtKB	Natural variant	383	383	.	.	.	ID=VAR_073231;Note=In BLAUS%3B unknown pathological significance%3B hyperactive. E->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19116920,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895493,PMID:19116920,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	383	383	.	.	.	ID=VAR_023823;Note=In BLAUS%3B hyperactive. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15812565,ECO:0000269|PubMed:19479837,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895477,PMID:15812565,PMID:19479837,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	391	391	.	.	.	ID=VAR_073232;Note=R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs104895481,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	414	414	.	.	.	ID=VAR_012681;Note=In IBD1%3B unknown pathological significance. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895429,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	431	431	.	.	.	ID=VAR_012682;Note=In IBD1%3B unknown pathological significance%3B no disruption of NOD2-CARD9 interaction. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:24960071;Dbxref=dbSNP:rs104895431,PMID:11385576,PMID:24960071	
Q9HC29	UniProtKB	Natural variant	432	432	.	.	.	ID=VAR_012683;Note=In IBD1%3B unknown pathological significance. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs2076754,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	441	441	.	.	.	ID=VAR_012684;Note=In IBD1%3B unknown pathological significance%3B no disruption of NOD2-CARD9 interaction. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:24960071;Dbxref=dbSNP:rs104895432,PMID:11385576,PMID:24960071	
Q9HC29	UniProtKB	Natural variant	463	463	.	.	.	ID=VAR_073233;Note=Polymorphism%3B no disruption of NOD2-CARD9 interaction. P->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16485124,ECO:0000269|PubMed:24960071;Dbxref=dbSNP:rs104895482,PMID:16485124,PMID:24960071	
Q9HC29	UniProtKB	Natural variant	464	464	.	.	.	ID=VAR_073234;Note=Polymorphism%3B hyperactive. G->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895492,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_012685;Note=In BLAUS%3B hyperactive. L->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11528384,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895460,PMID:11528384,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	471	471	.	.	.	ID=VAR_036872;Note=Polymorphism%3B does not affect activity. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs1078327,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	481	481	.	.	.	ID=VAR_073235;Note=In BLAUS%3B atypical form with cardiac infiltration%3B sporadic case%3B unknown pathological significance%3B hyperactive. G->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19359344,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895494,PMID:19359344,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	490	490	.	.	.	ID=VAR_073236;Note=In BLAUS%3B unknown pathological significance%3B hyperactive. W->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19479837,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895480,PMID:19479837,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	495	495	.	.	.	ID=VAR_073237;Note=In BLAUS%3B unknown pathological significance%3B hyperactive. C->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19116920,ECO:0000269|PubMed:19479837,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895478,PMID:19116920,PMID:19479837,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	496	496	.	.	.	ID=VAR_023824;Note=In BLAUS%3B hyperactive. H->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15459013,ECO:0000269|PubMed:19116920,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895472,PMID:15459013,PMID:19116920,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	507	507	.	.	.	ID=VAR_073180;Note=In BLAUS. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25692065;Dbxref=PMID:25692065	
Q9HC29	UniProtKB	Natural variant	513	513	.	.	.	ID=VAR_073238;Note=In BLAUS%3B hyperactive. M->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15459013,ECO:0000269|PubMed:19116920,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895473,PMID:15459013,PMID:19116920,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	550	550	.	.	.	ID=VAR_073239;Note=In IBD1%3B unknown pathological significance%3B no disruption of NOD2-CARD9 interaction. L->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15024686,ECO:0000269|PubMed:24960071;Dbxref=dbSNP:rs104895471,PMID:15024686,PMID:24960071	
Q9HC29	UniProtKB	Natural variant	587	587	.	.	.	ID=VAR_073240;Note=In BLAUS%3B unknown pathological significance%3B not hyperactive. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19479837,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895479,PMID:19479837,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	605	605	.	.	.	ID=VAR_065228;Note=In BLAUS%3B hyperactive. T->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19169908,ECO:0000269|PubMed:25093298;Dbxref=PMID:19169908,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	605	605	.	.	.	ID=VAR_073241;Note=In BLAUS%3B hyperactive. T->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15459013,ECO:0000269|PubMed:19116920,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895474,PMID:15459013,PMID:19116920,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	612	612	.	.	.	ID=VAR_012686;Note=In BLAUS and IBD1%3B unknown pathological significance. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:15459013;Dbxref=dbSNP:rs104895438,PMID:11385576,PMID:15459013	
Q9HC29	UniProtKB	Natural variant	612	612	.	.	.	ID=VAR_012687;Note=In IBD1%3B unknown pathological significance%3B no disruption of NOD2-CARD9 interaction. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:24960071;Dbxref=dbSNP:rs104895439,PMID:11385576,PMID:24960071	
Q9HC29	UniProtKB	Natural variant	670	670	.	.	.	ID=VAR_073242;Note=In BLAUS%3B hyperactive. N->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15459013,ECO:0000269|PubMed:19116920,ECO:0000269|PubMed:25093298;Dbxref=dbSNP:rs104895475,PMID:15459013,PMID:19116920,PMID:25093298	
Q9HC29	UniProtKB	Natural variant	684	684	.	.	.	ID=VAR_012688;Note=In IBD1%3B unknown pathological significance. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs5743276,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	702	702	.	.	.	ID=VAR_012689;Note=In IBD1 and YAOS%3B associated with disease susceptibility%3B no disruption of NOD2-CARD9 interaction%3B decreases half-life of protein%3B abolishes interaction with ANKHD1%2C ENTR1 and TRIM41%3B increases interaction with RIPK2 and PPP2R3B%3B decreases interaction with LDOC1 and PPP1R12C%3B no effect on interaction with CHMP5. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:16485124,ECO:0000269|PubMed:21914217,ECO:0000269|PubMed:24790089,ECO:0000269|PubMed:24960071,ECO:0000269|PubMed:27812135;Dbxref=dbSNP:rs2066844,PMID:11385576,PMID:16485124,PMID:21914217,PMID:24790089,PMID:24960071,PMID:27812135	
Q9HC29	UniProtKB	Natural variant	703	703	.	.	.	ID=VAR_012690;Note=In IBD1%3B also found in patients with ulcerative colitis%3B unknown pathological significance. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs5743277,PMID:11385576,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	713	713	.	.	.	ID=VAR_012691;Note=In IBD1%3B unknown pathological significance. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895440,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	713	713	.	.	.	ID=VAR_073243;Note=In IBD1%3B unknown pathological significance. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs104895483,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	725	725	.	.	.	ID=VAR_012692;Note=In IBD1%3B unknown pathological significance. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs5743278,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	755	755	.	.	.	ID=VAR_012693;Note=In IBD1%3B also found in patients with ulcerative colitis%3B unknown pathological significance. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs61747625,PMID:11385576,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	758	758	.	.	.	ID=VAR_012694;Note=In IBD1%3B unknown pathological significance. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895442,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	760	760	.	.	.	ID=VAR_073244;Note=In IBD1%3B unknown pathological significance. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs3813758,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	778	778	.	.	.	ID=VAR_012695;Note=In IBD1%3B unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895443,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	790	790	.	.	.	ID=VAR_024402;Note=R->Q;Dbxref=dbSNP:rs5743279	
Q9HC29	UniProtKB	Natural variant	790	790	.	.	.	ID=VAR_073245;Note=In IBD1%3B unknown pathological significance. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs62029861,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	791	791	.	.	.	ID=VAR_073246;Note=R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs104895484,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	793	793	.	.	.	ID=VAR_012696;Note=In IBD1%3B unknown pathological significance. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895444,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	825	825	.	.	.	ID=VAR_073247;Note=N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs104895485,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	843	843	.	.	.	ID=VAR_012697;Note=In IBD1%3B unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895445,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	849	849	.	.	.	ID=VAR_073248;Note=A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16485124;Dbxref=dbSNP:rs104895486,PMID:16485124	
Q9HC29	UniProtKB	Natural variant	852	852	.	.	.	ID=VAR_073249;Note=In IBD1%3B unknown pathological significance. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15024686;Dbxref=dbSNP:rs104895467,PMID:15024686	
Q9HC29	UniProtKB	Natural variant	853	853	.	.	.	ID=VAR_012698;Note=In IBD1%3B unknown pathological significance. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895446,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	863	863	.	.	.	ID=VAR_012699;Note=In IBD1%3B unknown pathological significance. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895447,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	885	885	.	.	.	ID=VAR_012700;Note=In IBD1%3B unknown pathological significance. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=PMID:11385576	
Q9HC29	UniProtKB	Natural variant	908	908	.	.	.	ID=VAR_012701;Note=In IBD1 and YAOS%3B associated with disease susceptibility%3B decreases half-life of protein%3B abolishes interaction with ANKHD1%2C ENTR1 and TRIM41%3B decreases interaction with RIPK2 and PPP1R12C%3B no effect on interaction with CHMP5%2C LDOC1 and PPP2R3B. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11087742,ECO:0000269|PubMed:11385576,ECO:0000269|PubMed:16485124,ECO:0000269|PubMed:24790089,ECO:0000269|PubMed:26070941,ECO:0000269|PubMed:27812135;Dbxref=dbSNP:rs2066845,PMID:11087742,PMID:11385576,PMID:16485124,PMID:24790089,PMID:26070941,PMID:27812135	
Q9HC29	UniProtKB	Natural variant	918	918	.	.	.	ID=VAR_012702;Note=A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895452,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	924	924	.	.	.	ID=VAR_012703;Note=In IBD1%3B unknown pathological significance. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs104895453,PMID:11385576	
Q9HC29	UniProtKB	Natural variant	955	955	.	.	.	ID=VAR_012704;Note=V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11385576;Dbxref=dbSNP:rs5743291,PMID:11385576	
Q9HC29	UniProtKB	Mutagenesis	305	305	.	.	.	Note=No activation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11087742;Dbxref=PMID:11087742	
Q9HC29	UniProtKB	Mutagenesis	379	379	.	.	.	Note=No disruption in NOD2-CARD9 interaction. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24960071;Dbxref=PMID:24960071	
